However, it was also evident that the fertilization rates were reduced when oocytes were removed from less mature follicles, as reflected by high androstenedione/ oestradiol ratios.
Introduction
Although it has been known for some time that mammalian oocytes can undergo meiotic matura¬ tion when removed from antral follicles and cultured in vitro (Pincus & Enzmann, 1935; Edwards, 1965) , such oocytes apparently have a limited capacity for normal fertilization and a very low frequency of preimplantation development (Cross & Brinster, 1970; Moor & Trounson, 1977) . It has been suggested that there is deficient cytoplasmic maturation in such spontaneously maturing oocytes, although nuclear maturation appears normal (Thibault, 1977) . The stage at which human oocytes acquire such maturity and capacity for normal development has not been clearly defined and in particular the relevance of the preovulatory LH surge to oocyte maturation has not been clarified. Trounson, Leeton & Wood (1982) have reported that the oocytes of sheep must remain within the follicle after LH or hCG for an obligatory phase of 6-12 h before removal, if normal embryo development is to be achieved. We have tried to determine whether such an obligatory phase exists in women and, if so, could the period of time be defined. Besides considering more basic questions of oocyte maturation, this study aimed to determine whether flexibility was poss¬ ible, within the context of clinical in-vitro fertilization programmes, in the timing of oocyte recovery after hCG administration. Present (Templeton et al, 1984) . For this study the adjustments described by Messinis, Templeton, Angeli & Aitken (1985) were used and hCG (Pregnyl: Organon, Harden, U.K.) 4500 i.u. was given intramuscularly on Day 16.
Laparoscopy was carried out using a standard technique, with C02 for intraperitoneal gas insufflation. All follicles^16 mm were aspirated. With the aid of microscopy, the oocyte was iden¬ tified in the follicular fluid and placed in culture medium (described below). The appearance of the cumulus, corona and follicle cells was noted. The volume of follicular fluid was measured, and aliquants were set aside for subsequent assay of oestradiol and androstenedione (Templeton et al, 1984) .
Timing of hCG administration and oocyte recovery. Each patient was allocated to one of four groups, depending on the interval between hCG administration and follicle aspiration. The first group had follicle aspiration on Day 16 of the fixed schedule without hCG administration (Group 1). In the remaining three groups follicle aspiration was carried out 12, 24 or 36 h after hCG (Groups 2, 3 and 4 respectively). Venous blood was withdrawn from each patient on admission to hospital (Day 15) and again immediately before hCG (or oocyte recovery in Group 1) for assay of plasma LH (Djahanbakhch, McNeilly, Hobson & Templeton, 1981) .
In-vitro oocyte culture. Oocytes were cultured in vitro before insemination for various times, i.e. 42, 30, 18 and 6 h for Groups 1, 2, 3 and 4 respectively. This was based on the optimal hCG-torecovery interval of 36 h, plus the 6-h pre-fertilization incubation of the oocyte suggested by Trounson et al (1982) . Insemination and culture techniques have been described previously (Angeli, Aitken, van Look, Lumsden & Templeton, 1983; Templeton et al, 1984) . The culture medium was Earles medium (Flow Laboratories, Stirling, U.K.) with sodium pyruvate and 8% heat-inactivated serum from the patient. The medium was bicarbonate-buffered and culture took place in a C02 incubator at 37°C. Insemination was carried out using donor spermatozoa of proven fertility prepared as previously described and at a concentration of 2 IO5 spermatozoa/ml.
After insemination, fertilization was confirmed by the appearance of pronuclei (when visible), and then signs of cleavage at the normal rate. After fertilization was confirmed, the oocytes were transferred to culture medium containing 15% patient's serum. In most cases, development was stopped between 4 and 8 cells by addition of colcemid in an attempt to obtain preparations for chromosome analysis (Angell et al, 1983) . These results will be reported in detail elsewhere. Development was sometimes allowed to proceed to the morula or blastocyst stage.
Results
The number of patients initially recruited into each group, and the reasons for and number of exclusions are shown in Table 1 . For the purposes of this study, any patient who had ovulated, or had a spontaneous LH surge before hCG administration, or had poor follicular response (no follicles^16 mm) was excluded. The number of follicles^16 mm aspirated in each group is also shown in Table 1 as is the average number of follicles per patient. This was similar (1-8-2-0) in all four groups. (Thebault, Testart, Castanier & Frydman, 1982) . We used this ratio rather than the measured concentration of hormone because of the marked decrease in concen¬ tration of oestradiol and androstenedione that takes place after the administration of hCG (Templeton, 1985) . The results are shown in Fig. 1 (Templeton et al, 1984; Messinis et al, 1985) . Other approaches to achieving a supply of mature human oocytes have been described in the context of different research objectives (Braude et al, 1984) . In this study 28% of 65 patients recruited did not provide suitable oocytes, either because of inadequate follicular development or because they had already ovulated or started an endogenous LH surge. In the remainder, about 2 follicles per patient were obtained and this is only slightly less than that obtained with similar ovulation induction regimens, but within the context of embryo transfer programmes (Quigley, Maklad & Wolf, 1983; Marrs, Vargyas, Shangold & Yee, 1984) .
The oocyte recovery rates in therapeutic programmes is very high (Johnston, 1985; Steptoe, 1985) , but then follicle aspiration is done in the optimal window just before ovulation (24 h after onset of the LH surge in urine and 36 h after an injection of hCG). The present study confirms that the laparoscopie oocyte recovery rate decreases significantly when recovery is attempted less than 24 h after the administration of hCG. The recovery rates when no hCG is given is only 36%, and this would be unacceptable within the context of current therapeutic regimens. Many of the oocytes recovered at this stage were identified only with difficulty in sheets of undissociated follicle cells, and their features could only be discerned after culture for about 24 h. However, the study has shown clearly that when these oocytes are identified and subjected to maturation in vitro before insemination, their fertilization and cleavage rates are not significantly less than those of oocytes that had 36 h of intrafollicular exposure to hCG. Indeed, oocytes recovered from follicles before exposure to the midcycle LH surge or to the administration of hCG can be fertilized after matura¬ tion culture in vitro and in this way differ from sheep oocytes (Trounson, 1982) which require an obligatory phase of 6-12 h in the follicle if normal fertilization is to be achieved. When cleavage occurred with the no hCG group (Group 1), it was at the normal rate and we could confirm that blastocyst formation was possible. Furthermore, all (Overstreet & Hembree, 1976; Edwards, Bavister & Steptoe, 1969) and that both FSH and LH increase sperm penetrability (Soupart & Morgenstern, 1973) . Nishimoto et al (1982) have shown that the number of oocytes penetrated by spermatozoa and showing an enlarged sperm head or male pronucleus increases during the follicular phase. Oocytes recovered around midcycle showed a 3-fold increase in sperm penetrability. Although we have been able to show that sperm penetration is not dependent on the midcycle gonadotrophin surge, provided the oocyte is matured in vitro before insemination, it would appear that the fertilization and cleavage rates were reduced when oocytes were removed from less mature follicles as reflected by high androstenedione: oestradiol ratios. The process of nuclear (meiotic) maturation in the human oocyte is remarkedly consistent both in vitro and in vivo after hCG or an endogenous LH surge. Germinal vesicle break¬ down occurs around 24 h after the ovulatory stimulus or removal from the follicle and the egg is arrested in metaphase II at around 32-36 h. Ovulation occurs 2-8 h after this (Edwards, 1973; Shea, Baker & Latour, 1975; Sei bel, Shine, Smith & Taymor, 1982; . Presumably, any attempts to fertilize the egg before the completion of this process would be in vain and, in this respect, possibly the delay in timing insemination of up to 42 h in this study was crucial. Trounson (1982) has reported problems with sheep and human oocytes for which early insemination is associated with abnormal fertilization and subsequent fragmentation of the embryo. It would therefore seem that early diploid cleavage and hence sperm penetration and pronuclear formation can be achieved in human oocytes that have not been exposed to the LH surge or hCG in the follicle. However, cytoplasmic maturation could not be fully assessed in this study and such assessment would depend on replacement of cleaving embryos in a recipient uterus, a step which we were not in a position to take and which, even in optimal circumstances, carries a low success rate in women. Schroeder & Eppig (1984) have shown that mouse oocytes at the germinal vesicle stage can undergo spontaneous maturation independent of gonadotrophin and steroids and normal develop¬ mental capacity was proved by the birth of live offspring. Schroeder & Eppig (1984) argued that the success was dependent on the culture medium and particularly on the addition of mouse serum. However, the time course of events in the mouse is considerably shorter than in women and sheep, and further study in this area is needed. We achieved in-vitro maturation only when oocytes were removed from mature follicles, and when the androstenedione:oestradiol ratio was more than 01, successful cleavage was seldom achieved. Almost certainly, oocytes removed before this stage will require further support if in-vitro maturation is to be achieved, and in this respect the addition of gonadotrophin and steroid to the culture medium would appear to be critical. Staigmiller & Moor (1984) have demonstrated the importance not only of these factors, but also of the support of adjacent follicle cells in the culture medium. Studies along these lines will have considerable benefit in clinical terms, particularly if robust in-vitro maturation systems could be developed which could obviate the need for the intensive midcycle monitoring that is currently required in embryo transfer programmes. However, bearing in mind the low recovery rate of immature oocytes using standard techniques, it may be necessary to develop new methods of follicle aspiration.
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